Hepatitis C virus proteins inhibit C3 complement production

Journal of Virology

Volumn 86, Issue 4, 2012, Pages 2221-2228

  Mazumdar, Budhaditya ^a   Kim, Hangeun ^a   Meyer, Keith ^a   Bose, Sandip K ^a   Di Bisceglie, Adrian M ^a   Ray, Ratna B ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENT COMPONENT C3; FARNESOID X RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTRUCTURAL PROTEIN 5A;

ARTICLE; CLINICAL ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER BIOPSY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENOME;

ANIMALS; CELL LINE, TUMOR; COMPLEMENT C3; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; PROMOTER REGIONS, GENETIC; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84863150484     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06577-11     Document Type: Article

References (43)

1. Ait-Goughoulte M, et al. 2010. Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response. Hepatology 51:1505-1513.
2. Akahane Y, et al. 1996. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C. Am. J. Gastroenterol. 91:319-327.
3. Ali OS, Abo-Shadi MA, Hammad LN. 2005. The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma. Egypt. J. Immunol. 12:91-99.
4. Aouadi M, et al. 2007. p38MAP Kinase activity is required for human primary adiposcyte differentiation. FEBS Lett. 581:5591-5596.
5. Avirutnan P, et al. 2010. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207:793-806.
6. Avirutnan P, et al. 2011. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187:424-433.
7. Banerjee A, Ray RB, Ray R. 2010. Oncogenic potential of hepatitis C virus proteins. Viruses 2:2108-2133.
8. Banerjee A, et al. 2011. Transcriptional repression of C4 complement by hepatitis C virus proteins. J. Virol. 85:4157-4166.
9. Basu A, Meyer K, Ray RB, Ray R. 2002. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 298:53-62.
10. Baumann H, Gauldie J. 1994. The acute phase response. Immunol. Today 15:74-80.
11. Carroll MC. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5:981-986.
12. Castell JV, et al. 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242:237-239.
13. Charles ED, Dustin LB. 2009. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 76:818-824.
14. + T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin. Immunol. 132:401-411.
15. Gabay C, Kushner I. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448-454.
16. Heinrich PC, Castell JV, Andus T. 1990. Interleukin-6 and the acutephase response. Biochem. J. 265:621-636.
17. Juan TS, Wilson DR, Wilde MD, Darlington GJ. 1993. Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc. Natl. Acad. Sci. U. S. A. 90:2584-2588.
18. Kanda T, et al. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
19. Kawamura N, Singer L, Wetsel RA, Colten HR. 1992. Cis-and transacting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene. Biochem. J. 283:705-712.
20. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106:1239-1249.
21. Krawczynski K, et al. 1992. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology 103:622-629.
22. Li J, Pircher PC, Schulman IG, Westin SK. 2005. Regulation of complement C3 expression by the bile acid receptor FXR. J. Biol. Chem. 280:7427-7434.
23. Liang Y, et al. 2009. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137:1448-1458.
24. Majumder M, Ghose AK, Steele R, Ray R, Ray RB. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J. Virol. 75:1401-1407.
25. Majumder M, et al. 2003. Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Lett. 555:528-532.
26. Maranto J, Rappaport J, Dutta PK. 2008. Regulation of complement component C3 in astrocytes by IL-1b and morphine. J. Neuroimmune Pharmacol. 3:43-51.
27. Maranto J, Rappaport J, Dutta PK. 2011. Role of C/EBP-β, p38 MAPK and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes. J. Cell. Biochem. 112:1168-1175.
28. Mehlhop E, Diamond MS. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
29. Moon MR, et al. 1999. Complement component C3 production in IL-1β-stimulated human intestinal epithelial cells is blocked by NF-κBα inhibitors and by transfection with ser 32/36 mutant IκBα. J. Surg. Res. 82:48-55.
30. Nakajima T, et al. 1993. Phosphorylation at threonine-235 by a rasdependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. U. S. A. 90:2207-2211.
31. Nomura H, et al. 1997. Hepatitis C virus-related liver damage is related to cold activation of complement. J. Clin. Gastroenterol. 25:529-534.
32. Pal S, et al. 2006. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J. Virol. 80:2280-2290.
33. Poli V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273:29279-29282.
34. Qin X, Gao B. 2006. The complement system in liver diseases. Cell. Mol. Immunol. 3:333-340.
35. Ramadori G, Christ B. 1999. Cytokines and the hepatic acute-phase response. Semin. Liver Dis. 19:141-155.
36. Ray RB, Steele R, Meyer K, Ray R. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:10983-10986.
37. Ray RB, Meyer K, Ray R. 2000. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271:197-204.
38. Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11:785-797.
39. Sansonno D, Lauletta G, Dammacco F. 2004. Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. J. Viral Hepat. 11:27-32.
40. Stapp JM, Sjoelund V, Lassiter HA, Feldhoff RC, Feldhoff PW. 2005. Recombinant rat IL-1β and IL-6 synergistically enhance C3 mRNA levels and complement component C3 secretion by H-35 rat hepatoma cells. Cytokine 30:78-85.
41. Sugano M, et al. 1995. Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction. J. Clin. Pathol. 48:820-825.
42. Wilson DR, Juan TS, Wilde MD, Fey GH, Darlington GJ. 1990. A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol. Cell. Biol. 10:6181-6191.
43. Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complementdependent regulatory pathway. J. Immunol. 167:5264-5272.